The US Food and Drug Administration (FDA) has granted Abbott an investigational device exemption to evaluate the company’s ...

The elderly patient had endured two months of suffering after falling from the bed. Thankfully, the fall led to accurate and ...

Abbott's Coronary IVL System wins FDA IDE nod, offering a potential new treatment for arterial calcium blockages.

Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) for its Coronary Intravascular Lithotripsy (IVL) System to ...

Abbott has announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) ...

Johnson & Johnson and Boston Scientific have also recently made moves to sell their own coronary intravascular lithotripsy ...

Abbott will be trying its hand in the growing field of intravascular lithotripsy, with a clinical study to examine an unnamed ...

Abbott (NYSE: ABT) received FDA investigational device exemption (IDE) approval for its coronary intravascular lithotripsy ...

Multibranched thoracoabdominal stent grafts have demonstrated broad applicability, especially for urgent repairs of ...

Critics say a new, broader definition of high-risk plaque opens the door to more tests, diagnoses, and invasive procedures, steering us down a potentially harmful path.

John Baker, MD, cardiologist with West Tennessee Medical Group, recently performed the first procedure using the AGENT™ ...

Health First Medical Group Nurse Practitioner Joy Cruz detected a troubling sound in Fred's carotid artery called a bruit.